_________ false
פלוריסטם תרפיוטיקס אינק 2 381
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8544

Israel Securities Authority   Tel Aviv Stock Exchange   C003 ( Public )   Reported via MAGNA: 04/06/2018
  www.isa.gov.il     www.tase.co.il       Reference: 2018-02-047259 Time of broadcast: 12:57 12:08:30

Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


Delay the publication of a report _________ _________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on
Announcing_date_for_IC_results_final_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       

Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 01/05/2018
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com

Previous names of reporting entity:

Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company:
Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: zami@pluristem.com 2